FDA Approved: ZYNRELEF — Supplemental Application (Heron Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZYNRELEF (bupivacaine and meloxicam) by Heron Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

SUPPL AP for ZYNRELEF (BUPIVACAINE AND MELOXICAM)